Dexin Corporation
USPTO PatentsView assignee record - 126 granted patents across 30 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06F (Electric Digital Data Processing).
The verdict
According to USPTO PatentsView, Dexin ranks #3,010 of 49,997 tracked US assignees by granted-patent volume, with 126 patents across 30 technology areas.
- #3,010
- of 49,997 US assignees by volume
- Top 16%
- by Innovation Score (48.6/100)
- 9.5
- avg claims per patent
- +29%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3010 · Foreign Corporation #3,010 · 126 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-MID 126 grants
- TOP-DECILE #3,010/49,997
- PHOTO-FINISH Abb Vie Deutschland…
- CPC-FOCUS G06F · 30 areas
- INNOV-PAR 48.6/100
- CLAIMS-PAR 9.5 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +29% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Abb Vie Deutschland Gmbh & Co. KG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Dexin’s 48.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Dexin
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Verizon Media · near
Verizon Media · near
49 score
- Abus August… · near
Abus August… · near
49 score
- Adva Optical… · near
Adva Optical… · near
49 score
- Dexin · this assignee
Dexin · this assignee
49 score
- Hydrogenics · near
Hydrogenics · near
49 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Dexin's Innovation Score is 48.6/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Dexin?
Each dot is one of Dexin’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dexin’s own 9.5 claims/patent is at or below the 18.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Dexin's grants concentrate
Dexin Corporation is a focused PatentsView assignee: 30 CPC subclasses with 60.3% of grants classified under G06F (Electric Digital Data Processing). Peak complete grant year is 2019 (18 grants) versus a trough of 2 in 2016. By volume, Dexin sits between Abb Vie Deutschland Gmbh & Co. KG and Fyusion, Inc..
Dexin's three-year grant acceleration
From 2019–2021 to 2022–2024, Dexin Corporation moved from 40 to 41 grants (1.02x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,118. See the growth leaderboard.
Who files at Dexin's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Abb Vie Deutschla…
Abb Vie Deutschland Gmbh & Co. KG
126 patents
- Chatsworth Produc…
Chatsworth Products, Inc.
126 patents
- Ceres
Ceres, Inc.
126 patents
- Cobra Golf Incorp…
Cobra Golf Incorporated
126 patents
- Dena
DeNA Co., Ltd.
126 patents
- Deutsche Post
Deutsche Post AG
126 patents
- Fair Isaac
Fair Isaac Corporation
126 patents
- Fyusion
Fyusion, Inc.
126 patents
- Dexin ◀
Dexin Corporation
126 patents
What this shows Dexin holds 126 patents at rank #3,008, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Dexin
By rank, the assignees closest to #3,008 in granted patent volume.
- Abb Vie Deutschland Gmbh & Co. KG #3,004 · 126 patents
- Chatsworth Products, Inc. #3,005 · 126 patents
- Ceres, Inc. #3,006 · 126 patents
- Cobra Golf Incorporated #3,007 · 126 patents
- DeNA Co., Ltd. #3,009 · 126 patents
- Deutsche Post AG #3,010 · 126 patents
- Fair Isaac Corporation #3,011 · 126 patents
- Fyusion, Inc. #3,012 · 126 patents
Leaders in G06F (Electric Digital Data Processing)
Other assignees with the most granted patents in Dexin's primary technology class.
- International Business Machines Corporation 42,717 in class
- Samsung Electronics Co., Ltd. 21,497 in class
- Microsoft Technology Licensing, LLC 16,951 in class
- Google LLC 13,092 in class
- Intel Corporation 12,803 in class
- Apple Inc. 11,007 in class
- Amazon Technologies, Inc. 10,217 in class
- Dell Products L.P. 7,187 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Dexin, neither rank-band nor same-CPC leaders (those blocks stay above). In G06F (Electric Digital Data Processing), Dexin ranks #683 of 13,878 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (49 here).
Similar claim depth
Nearest assignees by average claims per patent (9.5 here).
Dexin's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
49 Top 16% higher than 84% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 11 | 8.7% |
| 2016 | 2 | 1.6% |
| 2017 | 7 | 5.6% |
| 2018 | 11 | 8.7% |
| 2019 | 18 | 14.3% |
| 2020 | 8 | 6.3% |
| 2021 | 14 | 11.1% |
| 2022 | 18 | 14.3% |
| 2023 | 13 | 10.3% |
| 2024 | 10 | 7.9% |
| 2025partial year | 14 | 11.1% |
Which technologies does Dexin Corporation patent most?
Top 15 of 30 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Dexin Corporation's patent record in context - here's where to go next.
- Dexin Corporation's lead technology class is G06F (Electric Digital Data Processing), 60.3% of its portfolio - see every assignee active in that class. Explore G06F
- Ranked #3,010 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Dexin Corporation against Abb Vie Deutschland Gmbh & Co. KG, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 48.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.